课题基金 / 基金详情

Antibodies against erythrocyte invasion ligands of Plasmodium falciparum and protection from malaria

Antibodies against erythrocyte invasion ligands of Plasmodium falciparum and protection from malaria
抗恶性疟原虫红细胞侵袭配体的抗体和预防疟疾
批准号:
nhmrc : 516756
负责人:
Prof James Beeson
金额:
$23.88万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2009-12-31

项目摘要

项目成果

Prof James Beeson的其他基金

相似基金

相关文献

中文摘要
翻译
疟疾是全球儿童死亡的主要原因。疟疾寄生虫感染红细胞并在其中繁殖,如果不及时治疗,会导致严重的疾病。目前没有可用的疫苗,有效的治疗方法有限。在对非洲和巴布亚新几内亚儿童的研究中,我们的目标是确定阻断血液中疟疾感染和生长的免疫反应。有了这些知识,就可以设计针对疟疾的疫苗,以预防严重疾病和死亡。
英文摘要
Malaria is a leading cause of childhood death globally. Malaria parasites infect red blood cells and multiply inside them, resulting in severe illness if untreated. Currently there is no vaccine available and effective treatments are limited. In studies of children in Africa and PNG, we aim to identify immune responses that block infection and growth of malaria in the blood. With this knowledge, vaccines can be designed that target malaria to prevent serious illness and death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Malaria immunity and vaccines
  • 批准号:
    nhmrc : GNT1077636
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $75.08万
  • 财政年份:
    2015
  • 负责人:
    Prof James Beeson
  • 依托单位:
Malaria immunity and vaccines
Surface antigens of Plasmodium falciparum-infected erythrocytes and immunity to malaria in humans
Identifying the major targets of protective antibodies against malaria
海外基金